BVT 74316Alternative Names: BVT.74316; BVT74316
Latest Information Update: 15 Aug 2012
At a glance
- Originator Biovitrum
- Developer Proximagen
- Class Anorectics; Benzofurans; Obesity therapies
- Mechanism of Action Serotonin 6 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase I Obesity